{"hands_on_practices": [{"introduction": "A core principle of any self-sustaining oscillator is a delayed negative feedback loop. In this exercise [@problem_id:2728614], we explore this principle through a thought experiment that mimics a classic genetic knockout. By mathematically removing the Cryptochrome repressors from the system, you can calculate the new steady-state behavior and demonstrate precisely why negative feedback is essential for generating circadian rhythms.", "problem": "A core transcriptional-translational feedback loop in mammalian circadian clocks consists of the transcriptional activators CLOCK and Brain and Muscle Arnt-Like 1 (BMAL1) binding E-box motifs to activate Period 1 (Per1) and Period 2 (Per2) transcription, with the Period (PER) and Cryptochrome (CRY) proteins forming a repressive complex that inhibits CLOCK/BMAL1 activity. Consider a Cry1/Cry2 double knockout in which CLOCK/BMAL1 DNA binding is intact and constitutively competent to activate E-box-driven transcription in the absence of CRY-mediated repression. Assume the following widely used kinetic idealizations grounded in first-order kinetics and the Central Dogma of molecular biology: (i) transcription rate is proportional to activator drive, (ii) messenger RNA (mRNA) and protein are degraded by first-order processes, and (iii) translation rate is proportional to mRNA abundance.\n\nSpecifically, in the Cry1/Cry2 double knockout, take the effective CLOCK/BMAL1 transactivation drive to be constant and normalized to $A_{\\mathrm{DKO}} = 1$ (dimensionless). For Per1 and Per2, let transcription proportionality constants be $k_{\\mathrm{tx,Per1}} = 1.2\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}$ and $k_{\\mathrm{tx,Per2}} = 1.0\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}$, mRNA degradation rate constants be $k_{\\mathrm{dm,Per1}} = 0.3\\,\\mathrm{h}^{-1}$ and $k_{\\mathrm{dm,Per2}} = 0.5\\,\\mathrm{h}^{-1}$, translation proportionality constants be $k_{\\mathrm{tl,PER1}} = 0.8\\,\\mathrm{h}^{-1}$ and $k_{\\mathrm{tl,PER2}} = 1.2\\,\\mathrm{h}^{-1}$, and protein degradation rate constants (in the absence of CRY-mediated stabilization) be $k_{\\mathrm{dp,PER1}} = 0.4\\,\\mathrm{h}^{-1}$ and $k_{\\mathrm{dp,PER2}} = 0.6\\,\\mathrm{h}^{-1}$.\n\nUnder these assumptions, which option best describes the qualitative behavior (rhythmic versus arrhythmic; phase relationships) and the quantitative steady-state levels of Per1 and Per2 mRNA and protein in the Cry1/Cry2 double knockout?\n\nA. Per1 and Per2 mRNA become constitutively high and arrhythmic because the loss of CRY eliminates negative feedback on CLOCK/BMAL1 while leaving DNA binding intact; mRNA settle to time-invariant levels of approximately $4.0\\,\\mathrm{nM}$ (Per1) and $2.0\\,\\mathrm{nM}$ (Per2). PER1 and PER2 proteins also become arrhythmic and settle to steady-state levels of approximately $8.0\\,\\mathrm{nM}$ (PER1) and $4.0\\,\\mathrm{nM}$ (PER2). No circadian phase relationships persist.\n\nB. Per1 and Per2 mRNA become constitutively low or undetectable because CRY is required for CLOCK/BMAL1 DNA binding; PER1 and PER2 proteins are near zero and arrhythmic.\n\nC. Per1 and Per2 mRNA become constitutively high and arrhythmic, but PER1 and PER2 proteins remain very low (less than $1\\,\\mathrm{nM}$) because CRY is required for translation; any residual oscillations in proteins are driven by post-translational delays.\n\nD. Per1 and Per2 mRNA and protein retain self-sustained circadian oscillations with approximately $24\\,\\mathrm{h}$ period because PER alone can repress CLOCK/BMAL1; amplitudes are modestly reduced, but phases are preserved relative to wild type.", "solution": "The problem statement is subjected to validation and is found to be valid. It is scientifically grounded in the accepted core mechanism of the mammalian circadian clock, is well-posed with sufficient information to derive a unique solution, and is expressed in objective, quantitative language. There are no contradictions, ambiguities, or fatal flaws. We may proceed with the solution.\n\nThe problem describes a system where the negative feedback loop of the circadian clock is broken due to the knockout of *Cry1* and *Cry2* genes. The transcriptional activators, CLOCK and BMAL1, are constitutively active. We are tasked with determining the steady-state behavior of the system.\n\nLet $M_1(t)$ and $M_2(t)$ represent the concentrations of *Per1* and *Per2* mRNA, respectively. Let $P_1(t)$ and $P_2(t)$ represent the concentrations of PER1 and PER2 proteins, respectively. The concentrations are in units of $\\mathrm{nM}$.\n\nBased on the provided assumptions, we construct a system of linear ordinary differential equations.\n\nFor *Per1* mRNA ($M_1$) and PER1 protein ($P_1$):\n1.  The rate of transcription of *Per1* mRNA is proportional to the constant activator drive $A_{\\mathrm{DKO}}$. The production term is $k_{\\mathrm{tx,Per1}} A_{\\mathrm{DKO}}$.\n2.  The degradation of *Per1* mRNA follows first-order kinetics, with the degradation term being $k_{\\mathrm{dm,Per1}} M_1$.\nThe differential equation for $M_1$ is:\n$$ \\frac{dM_1}{dt} = k_{\\mathrm{tx,Per1}} A_{\\mathrm{DKO}} - k_{\\mathrm{dm,Per1}} M_1 $$\n3.  The rate of translation of PER1 protein is proportional to the *Per1* mRNA concentration, $M_1$. The production term is $k_{\\mathrm{tl,PER1}} M_1$.\n4.  The degradation of PER1 protein follows first-order kinetics, with the degradation term being $k_{\\mathrm{dp,PER1}} P_1$.\nThe differential equation for $P_1$ is:\n$$ \\frac{dP_1}{dt} = k_{\\mathrm{tl,PER1}} M_1 - k_{\\mathrm{dp,PER1}} P_1 $$\n\nSimilarly, for *Per2* mRNA ($M_2$) and PER2 protein ($P_2$):\n$$ \\frac{dM_2}{dt} = k_{\\mathrm{tx,Per2}} A_{\\mathrm{DKO}} - k_{\\mathrm{dm,Per2}} M_2 $$\n$$ \\frac{dP_2}{dt} = k_{\\mathrm{tl,PER2}} M_2 - k_{\\mathrm{dp,PER2}} P_2 $$\n\nSince the activator drive $A_{\\mathrm{DKO}}$ is a constant ($A_{\\mathrm{DKO}} = 1$) and there is no negative feedback, the system will not exhibit oscillations. Instead, it will reach a steady state where all time derivatives are zero. Let these steady-state concentrations be denoted by $M_{1,ss}$, $P_{1,ss}$, $M_{2,ss}$, and $P_{2,ss}$.\n\nAt steady state ($\\frac{d}{dt} = 0$):\nFor *Per1* mRNA:\n$$ 0 = k_{\\mathrm{tx,Per1}} A_{\\mathrm{DKO}} - k_{\\mathrm{dm,Per1}} M_{1,ss} $$\n$$ M_{1,ss} = \\frac{k_{\\mathrm{tx,Per1}} A_{\\mathrm{DKO}}}{k_{\\mathrm{dm,Per1}}} $$\nSubstituting the given values: $k_{\\mathrm{tx,Per1}} = 1.2\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}$, $k_{\\mathrm{dm,Per1}} = 0.3\\,\\mathrm{h}^{-1}$, and $A_{\\mathrm{DKO}} = 1$.\n$$ M_{1,ss} = \\frac{1.2\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}}{0.3\\,\\mathrm{h}^{-1}} = 4.0\\,\\mathrm{nM} $$\n\nFor PER1 protein:\n$$ 0 = k_{\\mathrm{tl,PER1}} M_{1,ss} - k_{\\mathrm{dp,PER1}} P_{1,ss} $$\n$$ P_{1,ss} = \\frac{k_{\\mathrm{tl,PER1}} M_{1,ss}}{k_{\\mathrm{dp,PER1}}} $$\nSubstituting the values: $M_{1,ss} = 4.0\\,\\mathrm{nM}$, $k_{\\mathrm{tl,PER1}} = 0.8\\,\\mathrm{h}^{-1}$, and $k_{\\mathrm{dp,PER1}} = 0.4\\,\\mathrm{h}^{-1}$.\n$$ P_{1,ss} = \\frac{(0.8\\,\\mathrm{h}^{-1})(4.0\\,\\mathrm{nM})}{0.4\\,\\mathrm{h}^{-1}} = 8.0\\,\\mathrm{nM} $$\n\nFor *Per2* mRNA:\n$$ 0 = k_{\\mathrm{tx,Per2}} A_{\\mathrm{DKO}} - k_{\\mathrm{dm,Per2}} M_{2,ss} $$\n$$ M_{2,ss} = \\frac{k_{\\mathrm{tx,Per2}} A_{\\mathrm{DKO}}}{k_{\\mathrm{dm,Per2}}} $$\nSubstituting the given values: $k_{\\mathrm{tx,Per2}} = 1.0\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}$, $k_{\\mathrm{dm,Per2}} = 0.5\\,\\mathrm{h}^{-1}$, and $A_{\\mathrm{DKO}} = 1$.\n$$ M_{2,ss} = \\frac{1.0\\,\\mathrm{nM}\\,\\mathrm{h}^{-1}}{0.5\\,\\mathrm{h}^{-1}} = 2.0\\,\\mathrm{nM} $$\n\nFor PER2 protein:\n$$ 0 = k_{\\mathrm{tl,PER2}} M_{2,ss} - k_{\\mathrm{dp,PER2}} P_{2,ss} $$\n$$ P_{2,ss} = \\frac{k_{\\mathrm{tl,PER2}} M_{2,ss}}{k_{\\mathrm{dp,PER2}}} $$\nSubstituting the values: $M_{2,ss} = 2.0\\,\\mathrm{nM}$, $k_{\\mathrm{tl,PER2}} = 1.2\\,\\mathrm{h}^{-1}$, and $k_{\\mathrm{dp,PER2}} = 0.6\\,\\mathrm{h}^{-1}$.\n$$ P_{2,ss} = \\frac{(1.2\\,\\mathrm{h}^{-1})(2.0\\,\\mathrm{nM})}{0.6\\,\\mathrm{h}^{-1}} = 4.0\\,\\mathrm{nM} $$\n\nSummary of results:\nThe system is arrhythmic. The steady-state concentrations are:\n- *Per1* mRNA: $M_{1,ss} = 4.0\\,\\mathrm{nM}$\n- PER1 protein: $P_{1,ss} = 8.0\\,\\mathrm{nM}$\n- *Per2* mRNA: $M_{2,ss} = 2.0\\,\\mathrm{nM}$\n- PER2 protein: $P_{2,ss} = 4.0\\,\\mathrm{nM}$\n\nNow, we evaluate each option.\n\nA. The option states that Per1 and Per2 mRNA become constitutively high and arrhythmic, settling to time-invariant levels of approximately $4.0\\,\\mathrm{nM}$ (Per1) and $2.0\\,\\mathrm{nM}$ (Per2). It also states that PER1 and PER2 proteins become arrhythmic and settle to steady-state levels of approximately $8.0\\,\\mathrm{nM}$ (PER1) and $4.0\\,\\mathrm{nM}$ (PER2). It concludes that no circadian phase relationships persist.\nThis statement provides the correct qualitative description (constitutively high, arrhythmic) and the quantitative values derived from our analysis are in exact agreement with the values given in this option.\nVerdict: **Correct**.\n\nB. The option claims mRNA levels are low or undetectable because CRY is required for CLOCK/BMAL1 DNA binding. This contradicts a fundamental premise of the problem, which explicitly states \"CLOCK/BMAL1 DNA binding is intact and constitutively competent\". Therefore, the reasoning is based on an incorrect premise relative to the problem definition.\nVerdict: **Incorrect**.\n\nC. This option claims that while mRNA levels are high and arrhythmic, protein levels remain very low (less than $1\\,\\mathrm{nM}$) because CRY is required for translation. The problem statement provides no basis for the claim that CRY is required for translation; its canonical role is in nuclear repression and PER protein stabilization. Furthermore, our calculation shows high steady-state protein levels ($8.0\\,\\mathrm{nM}$ and $4.0\\,\\mathrm{nM}$), directly contradicting the quantitative claim.\nVerdict: **Incorrect**.\n\nD. This option claims that self-sustained circadian oscillations are retained because PER alone can repress CLOCK/BMAL1. This is incorrect. The problem describes a scenario where the negative feedback loop is broken by the absence of the CRY proteins, which are stated to be part of the repressive complex. In such a linear system with constant input, the dynamics evolve towards a stable fixed point, not a limit cycle oscillation. The system must be arrhythmic.\nVerdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2728614"}, {"introduction": "A robust oscillator must not only generate a rhythm but also maintain stability and respond predictably to external stimuli. This practice [@problem_id:2728547] challenges you to predict the dynamic consequences of acutely perturbing protein degradation, a key regulatory process. By comparing a wild-type system to one lacking a specific E3 ligase, you will develop an intuition for how the turnover rates of repressor proteins dictate the phase and amplitude of the circadian clock.", "problem": "A central feature of the mammalian circadian pacemaker is a transcriptional-translational feedback loop in which the transcription factor heterodimer CLOCK–Brain and Muscle Arnt-like Protein 1 (CLOCK–BMAL1) activates transcription of Period (*Per*) and Cryptochrome (*Cry*) genes; Period 2 (PER2) and CRYPTOCHROME (CRY1 and CRY2) proteins then accumulate, form repressive complexes, and inhibit their own transcription, closing the loop. The amplitude and phase of molecular rhythms depend on the timely turnover of repressors by the ubiquitin–proteasome system (UPS), in which E3 ligases target substrates for proteasomal degradation. F-box and leucine-rich repeat protein 3 (FBXL3) is an adaptor of an E3 ligase that ubiquitinates CRY proteins, promoting their proteasomal degradation, thereby relieving repression at the appropriate circadian time. PER2 is also degraded by the UPS via distinct E3 ligases.\n\nYou are given two otherwise isogenic cell lines bearing a knock-in Period 2 luciferase reporter (Per2::Luc), which reports PER2 protein abundance as a continuous bioluminescent rhythm with period $T \\approx 24\\,\\mathrm{h}$: one line is FBXL3-intact (wild type), and the other is FBXL3-deficient (loss-of-function). Both lines exhibit robust Per2::Luc oscillations under vehicle. At circadian time (CT) $8$ (rising limb of PER2), you apply an acute proteasome inhibitor (e.g., MG132 at $10\\,\\mu\\mathrm{M}$) for $\\approx 4\\,\\mathrm{h}$, then wash out and record Per2::Luc for $ 48\\,\\mathrm{h}$. Assume that luciferase signal is proportional to PER2 abundance, that proteasome inhibition globally stabilizes UPS substrates during the pulse, and that FBXL3 deficiency primarily stabilizes CRY proteins across the circadian cycle.\n\nUsing only the core definitions of the feedback loop, repressor-mediated inhibition, and UPS-dependent turnover, predict the qualitative effects of this acute proteasome inhibition on the amplitude and phase of the Per2::Luc rhythm in the two genotypes, relative to vehicle controls. Amplitude is defined as $A = \\dfrac{x_{\\max} - x_{\\min}}{2}$ for one cycle after the perturbation, and phase shift $\\Delta \\phi$ is defined as positive for a delay of the next PER2 peak relative to vehicle.\n\nWhich statement best captures the expected outcome?\n\nA. FBXL3-intact cells: acute proteasome inhibition elevates the PER2 baseline, reducing $A$ (damping) and producing $\\Delta \\phi > 0$ (phase delay); FBXL3-deficient cells: smaller additional changes in $A$ and a smaller $\\Delta \\phi$ than in FBXL3-intact cells.\n\nB. FBXL3-intact cells: acute proteasome inhibition increases $A$ (larger oscillations) and advances phase ($\\Delta \\phi  0$); FBXL3-deficient cells: strong damping and a phase delay ($\\Delta \\phi > 0$).\n\nC. Both genotypes exhibit essentially identical damping of $A$ and identical phase delays after proteasome inhibition because proteasomal blockade dominates over E3 ligase specificity.\n\nD. FBXL3-intact cells: acute proteasome inhibition reduces $A$ but advances phase; FBXL3-deficient cells: reduces $A$ with a larger phase advance than FBXL3-intact cells.", "solution": "The problem will be validated by first extracting the given information and then assessing its scientific and logical integrity.\n\n### Step 1: Extract Givens\n- **Core Molecular Loop**: The transcription factor heterodimer CLOCK–BMAL1 activates the transcription of *Per* (Period) and *Cry* (Cryptochrome) genes.\n- **Negative Feedback**: The protein products, PER2 and CRY, form repressive complexes that inhibit CLOCK–BMAL1, thus inhibiting their own transcription.\n- **Protein Degradation**: The turnover of PER2 and CRY proteins is mediated by the ubiquitin–proteasome system (UPS).\n- **CRY Degradation**: The E3 ligase adaptor FBXL3 specifically targets CRY proteins for ubiquitination and subsequent proteasomal degradation.\n- **PER2 Degradation**: PER2 is degraded by the UPS through distinct E3 ligases, not involving FBXL3.\n- **Experimental System**: Two cell lines, FBXL3-intact (wild type) and FBXL3-deficient (loss-of-function), both containing a *Per2*::*Luc* (luciferase) reporter.\n- **Reporter Signal**: The bioluminescent signal is proportional to the abundance of PER2 protein.\n- **Baseline Oscillations**: Both cell lines exhibit robust oscillations with a period $T \\approx 24\\,\\mathrm{h}$.\n- **Perturbation**: An acute pulse of a proteasome inhibitor is applied for $\\approx 4\\,\\mathrm{h}$.\n- **Timing of Perturbation**: The pulse starts at circadian time (CT) $8$. CT$8$ is defined as the rising limb of PER2 abundance.\n- **Assumptions**:\n    1. Luciferase signal is proportional to PER2 abundance.\n    2. Proteasome inhibition globally stabilizes all UPS substrates during the pulse.\n    3. FBXL3 deficiency primarily stabilizes CRY proteins throughout the cycle.\n- **Definitions**:\n    1. Amplitude: $A = \\dfrac{x_{\\max} - x_{\\min}}{2}$.\n    2. Phase shift: $\\Delta \\phi  0$ for a phase delay.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement describes the canonical mammalian circadian transcriptional-translational feedback loop, a cornerstone of modern chronobiology. The roles of CLOCK-BMAL1, PER/CRY proteins, the UPS, and the specific E3 ligase FBXL3 are scientifically established facts. The experimental design—using a *Per2*::*Luc* reporter, a proteasome inhibitor (like MG132), and analysis of amplitude and phase shifts—is a standard methodology in the field. The provided definitions and assumptions are clear, self-contained, and consistent. The problem is well-posed, asking for a qualitative prediction based on a clearly defined initial state and perturbation. There are no scientific inaccuracies, logical contradictions, or ambiguities.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. A solution will be derived.\n\n### Derivation of Solution\n\nThe problem requires predicting the effect of acute proteasome inhibition on the circadian oscillator in two different genetic backgrounds. The analysis must be performed by considering the state of the system at the time of perturbation and the specific roles of the involved proteins.\n\n**1. State of the System at CT8**\nAt CT$8$, the system is on the rising limb of PER2 protein accumulation. This corresponds to a phase where *Per* and *Cry* transcription, driven by CLOCK–BMAL1, is high. The levels of the repressor proteins PER2 and CRY are increasing but have not yet reached their peak; thus, feedback repression is building but is not yet maximal.\n\n**2. Effect of Proteasome Inhibition**\nThe proteasome inhibitor, applied from CT$8$ to approximately CT$12$, blocks the degradation of proteins targeted by the UPS. In this context, it will prevent the degradation of both PER2 and CRY proteins.\n\n**3. Analysis of FBXL3-intact (Wild-Type) Cells**\n- **Direct Effect of Inhibition**: In wild-type cells, both PER2 and CRY proteins are normally subject to continuous degradation by the UPS. The application of the inhibitor from CT$8$ to CT$12$ will block the degradation of both. Since transcription is high during this interval, the lack of degradation will cause a rapid and abnormally high accumulation of both PER2 and CRY proteins compared to the vehicle control.\n- **Feedback Consequences**: The PER/CRY complex is the functional repressor. The artificially high levels of both components (PER2 and CRY) create a much stronger repressor pool, which will lead to a premature and more potent inhibition of CLOCK–BMAL1-mediated transcription.\n- **Phase Shift ($\\Delta \\phi$)**: By inducing strong repression earlier in the cycle than normal, the phase of transcription is acutely shifted. The subsequent period of transcriptional repression will be prolonged because it will take longer for the cell to clear the artificially high concentration of repressor proteins, even after the inhibitor is washed out. A prolonged repression phase means that the initiation of the next cycle of transcription is delayed. This delay in transcription will propagate to a delay in the peak of PER2 protein in the next cycle. Therefore, a phase delay is expected, meaning $\\Delta \\phi  0$.\n- **Amplitude ($A$)**: Such a strong, mistimed perturbation is disruptive to a stable limit-cycle oscillator. The pulse of inhibitor creates an artificial surge in PER2 levels. The subsequent profound repression smothers the next wave of transcription. This leads to a lower peak ($x_{\\max}$) in the following cycle. The trough ($x_{\\min}$) may be elevated due to the residual high levels of protein. A decrease in $x_{\\max}$ and an increase in $x_{\\min}$ both lead to a reduction in amplitude $A = (x_{\\max} - x_{\\min})/2$. This phenomenon is known as damping.\n- **Conclusion for FBXL3-intact cells**: Expect a reduction in amplitude (damping) and a phase delay ($\\Delta \\phi  0$).\n\n**4. Analysis of FBXL3-deficient (Loss-of-Function) Cells**\n- **Baseline State**: In these cells, the primary E3 ligase for CRY, FBXL3, is absent. As per the problem's assumption, CRY proteins are already constitutively stabilized. Their degradation rate is very low. The degradation of PER2 via its distinct E3 ligases is unaffected and proceeds normally.\n- **Effect of Inhibition**: When the proteasome inhibitor is applied, it will block the degradation of PER2, causing it to accumulate rapidly, just as in the wild-type cells. However, for CRY proteins, the effect will be minimal. Since their main degradation pathway is already non-functional, a general proteasome inhibitor cannot cause a significant *additional* stabilization.\n- **Comparison to Wild-Type**: The key difference lies in the stabilization of the repressor complex. In wild-type cells, the inhibitor stabilizes *both* PER2 and CRY. In FBXL3-deficient cells, the inhibitor primarily stabilizes *only* PER2, as CRY is already stable. Therefore, the total increase in repressor strength during the pulse is substantially less in FBXL3-deficient cells than in wild-type cells.\n- **Phase and Amplitude Effects**: Because the magnitude of the perturbation (acute stabilization of the total repressor pool) is smaller in FBXL3-deficient cells, the resulting disruption to the oscillator will be attenuated. The premature repression will be weaker, the phase shift will be smaller, and the damping of amplitude will be less severe.\n- **Conclusion for FBXL3-deficient cells**: Expect effects in the same direction as wild-type (damping and phase delay), but with a smaller magnitude. Specifically, the change in $A$ will be less, and the phase delay $\\Delta \\phi$ will be smaller than in FBXL3-intact cells.\n\n### Option-by-Option Analysis\n\n**A. FBXL3-intact cells: acute proteasome inhibition elevates the PER2 baseline, reducing $A$ (damping) and producing $\\Delta \\phi  0$ (phase delay); FBXL3-deficient cells: smaller additional changes in $A$ and a smaller $\\Delta \\phi$ than in FBXL3-intact cells.**\n- This statement accurately reflects the derived consequences. For FBXL3-intact cells, it correctly predicts damping (reduced $A$) and a phase delay ($\\Delta \\phi  0$). The elevation of the baseline is a correct contributing factor to the damping. For FBXL3-deficient cells, it correctly predicts that the effects on both amplitude and phase will be smaller in magnitude compared to the wild-type response.\n- **Verdict**: Correct.\n\n**B. FBXL3-intact cells: acute proteasome inhibition increases $A$ (larger oscillations) and advances phase ($\\Delta \\phi  0$); FBXL3-deficient cells: strong damping and a phase delay ($\\Delta \\phi  0$).**\n- This statement is incorrect on multiple points. For FBXL3-intact cells, it wrongly predicts an increase in amplitude and a phase advance. A strong mistimed repressive signal causes damping and delay. For FBXL3-deficient cells, it wrongly predicts \"strong\" damping when the effect should be weaker than in wild-type.\n- **Verdict**: Incorrect.\n\n**C. Both genotypes exhibit essentially identical damping of $A$ and identical phase delays after proteasome inhibition because proteasomal blockade dominates over E3 ligase specificity.**\n- This statement incorrectly dismisses the central premise of the experimental comparison. The genetic difference between the cell lines (presence or absence of FBXL3) is designed to reveal the specific role of CRY degradation. The response to a global inhibitor *must* be different because the baseline state of CRY stability is different. The effect of the inhibitor is not additive but depends on the pre-existing state of the degradation pathways.\n- **Verdict**: Incorrect.\n\n**D. FBXL3-intact cells: acute proteasome inhibition reduces $A$ but advances phase; FBXL3-deficient cells: reduces $A$ with a larger phase advance than FBXL3-intact cells.**\n- This statement correctly predicts amplitude reduction for the wild-type but incorrectly predicts a phase advance ($\\Delta \\phi  0$). As derived, a phase delay is expected. The prediction for FBXL3-deficient cells has the wrong direction for phase shift and the wrong relative magnitude.\n- **Verdict**: Incorrect.", "answer": "$$\\boxed{A}$$", "id": "2728547"}, {"introduction": "Understanding the molecular clock often involves using small molecules to modulate its components and observing the outcome. This computational exercise [@problem_id:2728602] puts you in the role of a quantitative biologist analyzing experimental data from such a study. You will derive the standard dose-response model from basic principles and then apply it to fit real-world-style data, extracting key pharmacological parameters that describe how a compound alters the clock's period.", "problem": "You are modeling how a small-molecule inhibitor modulates the period of a circadian oscillator driven by a transcriptional-translational feedback loop (TTFL) in the context of cellular and molecular neuroscience. The biological foundation starts from well-tested principles: (i) the Central Dogma of Molecular Biology states that proteins are translated from messenger RNA, (ii) circadian TTFL dynamics are regulated by delayed negative feedback in which Protein Period and Cryptochrome complexes repress their own transcription after nuclear entry, and (iii) ligand-target binding under mass-action kinetics yields a saturable occupancy that increases monotonically with ligand concentration and displays cooperativity governed by a Hill coefficient. Under these foundations, assume that the drug modulates the rate-limiting step that sets the effective delay in the TTFL, such that the observed period is a saturating, monotonic function of target occupancy.\n\nYour tasks:\n- Starting from the stated foundations (mass-action binding and a monotone saturating link between occupancy and period), derive a parametric, saturable, cooperative response model that maps drug concentration $c$ in micromolar to circadian period $P(c)$ in hours. The model must include baseline period $P_0$ at $c=0$, an asymptotic period increase $\\Delta P_{\\max}$, a half-maximal concentration $EC_{50}$ in micromolar, and a Hill coefficient $n_H$ (dimensionless).\n- Using the derived model, estimate $EC_{50}$ and $n_H$ from each of the datasets below by nonlinear regression, treating $P_0$ and $\\Delta P_{\\max}$ as nuisance parameters to be fitted jointly. Your algorithm must enforce $EC_{50}  0$ and $n_H  0$, and must be robust to the datapoint at $c=0$.\n- Express the final $EC_{50}$ in micromolar and $n_H$ as dimensionless floats, each rounded to $4$ decimal places.\n\nData are noiseless mean values from multiple biological replicates (already averaged). Concentrations are in micromolar ($\\mu$M), and periods are in hours (h).\n\nTest Suite (three cases to cover typical, shallow, and highly cooperative responses):\n\n- Case A (typical monotone saturating increase):\n  - Concentrations $c_A$: $[0,\\,0.5,\\,1,\\,2,\\,5,\\,10,\\,20]$\n  - Periods $P_A$: $[24.0,\\,24.35294118,\\,25.2,\\,27.0,\\,29.17241379,\\,29.76923077,\\,29.94059406]$\n\n- Case B (shallow, nearly non-cooperative increase):\n  - Concentrations $c_B$: $[0,\\,1,\\,2,\\,4,\\,8,\\,16,\\,32]$\n  - Periods $P_B$: $[24.0,\\,24.33333333,\\,24.6,\\,25.0,\\,25.5,\\,26.0,\\,26.4]$\n\n- Case C (highly cooperative increase):\n  - Concentrations $c_C$: $[0,\\,0.05,\\,0.1,\\,0.2,\\,0.5,\\,1,\\,2]$\n  - Periods $P_C$: $[23.5,\\,23.50449550,\\,23.53571429,\\,23.77067669,\\,25.75,\\,27.5,\\,27.93076923]$\n\nRequired output:\n- Your program must estimate $EC_{50}$ and $n_H$ for each case and print a single line containing a comma-separated list with the values in this exact order: $[EC50\\_A, n\\_H\\_A, EC50\\_B, n\\_H\\_B, EC50\\_C, n\\_H\\_C]$, with each float rounded to $4$ decimal places.\n- Units: Report $EC_{50}$ in $\\mu$M and $n_H$ as dimensionless numbers.\n\nConstraints and verification:\n- The response model must be derived from the foundations listed above (mass action and monotone saturating occupancy-response link). Do not use any pre-specified shortcut formulas in your design phase; derive the model structure directly from these principles.\n- Ensure numerical stability and enforce $EC_{50}  0$ and $n_H  0$ during fitting.\n- The final printed line must match exactly the specified format, with no extra spaces.\n\nYour program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets (e.g., \"[result1,result2,result3,result4,result5,result6]\").", "solution": "The problem requires the derivation of a theoretical model for drug-induced modulation of circadian period, followed by the application of this model to estimate key parameters from provided datasets. The validation confirms the problem is scientifically grounded, well-posed, and objective. We proceed with the solution.\n\nFirst, we derive the response model, $P(c)$, which maps drug concentration $c$ to the circadian period. The derivation is based on the stated principles of mass-action kinetics and a linear stimulus-response coupling.\n\nLet the drug molecule (ligand) be denoted by $L$ and its cellular target (receptor) by $R$. The problem states the interaction is cooperative. The binding of $n_H$ ligands to one receptor is described by the reversible reaction:\n$$ n_H L + R \\rightleftharpoons R L_{n_H} $$\nwhere $n_H$ is the Hill coefficient, a measure of cooperativity.\n\nUnder the law of mass action, the dissociation constant, $K_D$, for this reaction at equilibrium is:\n$$ K_D = \\frac{[R][L]^{n_H}}{[R L_{n_H}]} $$\nHere, $[R]$, $[L]$, and $[R L_{n_H}]$ are the equilibrium concentrations of the free receptor, free ligand, and the complex, respectively. The total concentration of receptors, $[R]_{total}$, is the sum of free and bound receptors:\n$$ [R]_{total} = [R] + [R L_{n_H}] $$\nThe fractional occupancy, $\\theta$, is the fraction of total receptors that are bound by the ligand:\n$$ \\theta = \\frac{[R L_{n_H}]}{[R]_{total}} $$\nBy substituting $[R] = [R]_{total} - [R L_{n_H}]$ into the expression for $K_D$, we get:\n$$ K_D = \\frac{([R]_{total} - [R L_{n_H}])[L]^{n_H}}{[R L_{n_H}]} $$\nRearranging to solve for the ratio $[R L_{n_H}] / [R]_{total}$:\n$$ K_D [R L_{n_H}] = [R]_{total}[L]^{n_H} - [R L_{n_H}][L]^{n_H} $$\n$$ [R L_{n_H}](K_D + [L]^{n_H}) = [R]_{total}[L]^{n_H} $$\n$$ \\theta = \\frac{[R L_{n_H}]}{[R]_{total}} = \\frac{[L]^{n_H}}{K_D + [L]^{n_H}} $$\nThis is the Hill-Langmuir equation. We replace the ligand concentration $[L]$ with the variable $c$. In pharmacodynamics, it is standard to express this relationship using the half-maximal effective concentration, $EC_{50}$. This is the concentration $c$ at which the occupancy $\\theta$ is $0.5$. Setting $\\theta = 0.5$ and $c = EC_{50}$ gives:\n$$ 0.5 = \\frac{EC_{50}^{n_H}}{K_D + EC_{50}^{n_H}} \\implies K_D + EC_{50}^{n_H} = 2 \\cdot EC_{50}^{n_H} \\implies K_D = EC_{50}^{n_H} $$\nSubstituting this back into the equation for occupancy gives the standard form of the Hill equation:\n$$ \\theta(c) = \\frac{c^{n_H}}{EC_{50}^{n_H} + c^{n_H}} $$\nNext, we link occupancy $\\theta(c)$ to the observable period $P(c)$. The problem states this relationship is saturating and monotonic. The simplest such relationship is a linear mapping:\n$$ P(c) = P_{min} + (P_{max} - P_{min})\\theta(c) $$\nThe parameters are defined as:\n- $P_0$: the baseline period at zero drug concentration ($c=0$). At $c=0$, occupancy $\\theta(0)=0$, so $P(0) = P_{min}$. Thus, $P_{min} = P_0$.\n- $\\Delta P_{\\max}$: the asymptotic period increase. This is the difference between the period at saturating concentration ($c \\to \\infty$, where $\\theta \\to 1$) and the baseline period. Thus, $\\Delta P_{\\max} = P_{max} - P_0$.\n\nSubstituting these definitions, we have $P_{max} = P_0 + \\Delta P_{\\max}$, and the relationship becomes:\n$$ P(c) = P_0 + (P_0 + \\Delta P_{\\max} - P_0)\\theta(c) = P_0 + \\Delta P_{\\max} \\theta(c) $$\nCombining the expressions for $P(c)$ and $\\theta(c)$ yields the final four-parameter model:\n$$ P(c) = P_0 + \\Delta P_{\\max} \\left( \\frac{c^{n_H}}{EC_{50}^{n_H} + c^{n_H}} \\right) $$\nThis model is consistent with all stated principles and will be used for parameter estimation.\n\nThe parameters $\\{P_0, \\Delta P_{\\max}, EC_{50}, n_H\\}$ are estimated by fitting this model to the provided datasets using nonlinear least-squares regression. This procedure minimizes the sum of squared residuals between the model's predictions and the observed data points. The constraints $EC_{50}  0$ and $n_H  0$ are enforced as they are physically required. Given that the data are specified as noiseless, the fitting algorithm is expected to recover the true underlying parameters with high precision.\n\nThe analysis reveals that the data for each case were generated from the derived model with specific integer or simple rational parameters.\n- For Case A, the parameters are $P_0=24.0$, $\\Delta P_{\\max}=6.0$, $EC_{50}=2.0$, and $n_H=2.0$.\n- For Case B, the parameters are $P_0=24.0$, $\\Delta P_{\\max}=3.0$, $EC_{50}=8.0$, and $n_H=1.0$.\n- For Case C, the parameters are $P_0=23.5$, $\\Delta P_{\\max}=4.5$, $EC_{50}=0.5$, and $n_H=3.0$.\n\nA numerical fitting routine, such as Levenberg-Marquardt as implemented in `scipy.optimize.curve_fit`, will converge to these exact values. The program in the final answer implements this procedure, extracts the required parameters $EC_{50}$ and $n_H$ for each case, and formats the output as specified.", "answer": "```python\nimport numpy as np\nfrom scipy.optimize import curve_fit\n\ndef solve():\n    \"\"\"\n    Derives a circadian period modulation model and estimates its parameters\n    from three datasets using nonlinear regression.\n    \"\"\"\n\n    def hill_model(c, P0, delta_P_max, EC50, nH):\n        \"\"\"\n        Calculates the period P as a function of concentration c based on the\n        four-parameter Hill equation for a stimulatory response.\n\n        Args:\n            c (np.ndarray): Drug concentrations.\n            P0 (float): Baseline period at c=0.\n            delta_P_max (float): Asymptotic maximum period increase.\n            EC50 (float): Half-maximal effective concentration.\n            nH (float): Hill coefficient.\n\n        Returns:\n            np.ndarray: Predicted periods.\n        \"\"\"\n        # Use np.maximum to ensure concentration is non-negative, a safeguard.\n        c_safe = np.maximum(c, 0)\n        # To prevent potential 0**negative_power issues, though nH is bounded  0.\n        # This term correctly handles c=0, yielding 0.\n        term = (c_safe**nH) / (EC50**nH + c_safe**nH)\n        return P0 + delta_P_max * term\n\n    # Test cases defined in the problem statement.\n    # Each case includes concentration (c), period (P), and a good initial\n    # guess (p0) for the optimization, derived from data inspection.\n    test_cases = [\n        {\n            # Case A (typical monotone saturating increase)\n            'c': np.array([0, 0.5, 1, 2, 5, 10, 20]),\n            'P': np.array([24.0, 24.35294118, 25.2, 27.0, 29.17241379, 29.76923077, 29.94059406]),\n            'p0': [24.0, 6.0, 2.0, 2.0]\n        },\n        {\n            # Case B (shallow, nearly non-cooperative increase)\n            'c': np.array([0, 1, 2, 4, 8, 16, 32]),\n            'P': np.array([24.0, 24.33333333, 24.6, 25.0, 25.5, 26.0, 26.4]),\n            'p0': [24.0, 3.0, 8.0, 1.0]\n        },\n        {\n            # Case C (highly cooperative increase)\n            'c': np.array([0, 0.05, 0.1, 0.2, 0.5, 1, 2]),\n            'P': np.array([23.5, 23.50449550, 23.53571429, 23.77067669, 25.75, 27.5, 27.93076923]),\n            'p0': [23.5, 4.5, 0.5, 3.0]\n        }\n    ]\n\n    results = []\n    \n    # Define bounds for the parameters [P0, delta_P_max, EC50, nH].\n    # This enforces the constraints EC50  0 and nH  0.\n    # A small positive number is used for the lower bound to avoid issues at zero.\n    bounds = ([0.0, 0.0, 1e-9, 1e-9], [np.inf, np.inf, np.inf, np.inf])\n\n    for case in test_cases:\n        # Perform nonlinear least-squares fitting.\n        # 'trf' (Trust Region Reflective) is suitable for bounded problems.\n        popt, _ = curve_fit(\n            hill_model,\n            case['c'],\n            case['P'],\n            p0=case['p0'],\n            bounds=bounds,\n            method='trf'\n        )\n        \n        # Unpack the optimized parameters.\n        _, _, EC50_fit, nH_fit = popt\n        \n        # Append the required parameters to the results list.\n        results.append(EC50_fit)\n        results.append(nH_fit)\n\n    # Format the final output string as a comma-separated list of values\n    # rounded to 4 decimal places, enclosed in square brackets.\n    output_str = ','.join([f'{val:.4f}' for val in results])\n    print(f\"[{output_str}]\")\n\nsolve()\n```", "id": "2728602"}]}